An analysis of seven international clinical trials demonstrates that critically ill COVID-19 patients benefit from corticosteroid drugs. The studies found that steroids reduced the risk of death by 20%. The steroid drugs worked in all patients, regardless of gender, age, or duration of illness. With 21 strategically located depots around the world, Yourway is the partner of choice to help international clinical trials go according to plan.